Headache Disorders Global Market Report 2023

“Headache Disorders Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on headache disorders market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for headache disorders? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The headache disorders market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Migraine; Tension-Type Headache; Cluster Headache; Medication-Overuse Headache; Other Types

• 2) By Treatment: Medication; Heat Therapy; Diet Changes; Acupuncture; Oxygen Therapy

• 3) By Diagnosis: Complete Blood Count; Skull X-Rays; Sinus X-Rays; CT Scan; Magnetic Resonance Imaging (MRI)

• 4) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations

• 5) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users

• Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Hikma Pharmaceuticals PLC; Dr. Reddy's Laboratories Ltd; Novartis AG; Eli Lilly and Company

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the headache disorders market are Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd, Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd, Emcure Pharmaceuticals Limited, Endo International plc, WorldMeds LLC, AstraZeneca plc, Bausch & Lomb Incorporated, Nichi-Iko Pharmaceutical Co, Upsher-Smith Laboratories LLC, Bristol-Myers Squibb Company, Bayer AG, Boehringer Ingelheim International GmbH., Gilead Sciences Inc., and Amgen Inc.

The global headache disorders market is expected to grow from $4.07 billion in 2022 to $4.36 billion in 2023 at a compound annual growth rate (CAGR) of 7.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The headache disorders market is expected to reach $5.71 billion in 2027 at a CAGR of 7%.

The headache disorders market includes revenues earned by entities by providing analgesics, anti-emetics, specific anti-migraine medications, and prophylactic medications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Headache disorder is a neurological disorder that is characterized by severe headaches that eoccur on one side of the head, usually around the eye. Headache disorders create a major burden on sufferers, including significant personal pain, decreased quality of life, and financial consequences.

North America was the largest region in the headache disorders market in 2022. The regions covered in headache disorders report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of headache disorders are migraine, tension-type headaches, cluster headaches, medication-overuse headaches, and others. A migraine headache is characterized by intense throbbing pain or a pulsating sensation, typically on one side of the brain. The various treatment involved are medication, heat therapy, diet changes, acupuncture, and oxygen therapy which are diagnosed by complete blood count, skull x-rays, sinus x-rays, ct scans and magnetic resonance imaging (MRI) through oral, parenteral, others and are used for hospitals, specialty clinics, homecare, others.

The increasing prevalence of migraine is expected to propel the growth of the headache disorders market going forward. Migraine refers to a type of headache that is characterized by recurring episodes of moderate to severe throbbing and pulsating pain on one side of the head. Headache disorders can cause neurological disorders causing crippling throbbing pain, tiredness, nausea that may cause migraine. For instance, according to Migraine.com, part of US-based Health Union, LLC which provide people living with chronic conditions the information, connection and validation they seek, in 2021, around 39 million people in the United States and 1 billion people worldwide have migraine. Therefore, the increasing prevalence of migraine is driving the demand for the headache disorders market.

Product innovation is a key trend gaining popularity in the headache disorder market. Major companies operating in the headache disorder market are focused on developing innovative products to strengthen their position in the market. For instance, in September 2021, AbbVie, a US-based pharmaceutical company that discovers develops, and markets both biopharmaceuticals and small molecule drugs, launched QULIPTATM (atonement) a prescription medicine for the preventative treatment of episodic migraine in adults. It is uniquely formulated with oral calcitonin gene-related peptide (CGRP) receptor antagonist (giant) in three dose sizes of 10 mg, 30 mg, and 60 mg which are approved by The U.S. Food and Drug Administration (FDA), a US-based department of health.

In May 2022, Man and Science SA, a Belgium-based medical device company, acquired Palion Medical AS for an undisclosed amount. The acquisition of Palion Medical fits well into Man and Science's headache treatment offerings and further drives Man ad Science's ability to provide several therapy solutions to improve patient care. Palion Medical AS a Germany-based clinical-stage medical device company developing a precision injection solution for people suffering from debilitating chronic migraine and cluster headaches.

The countries covered in the headache disorders market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The headache disorders market research report is one of a series of new reports from The Business Research Company that provides headache disorders market statistics, including headache disorders industry global market size, regional shares, competitors with headache disorders market share, detailed headache disorders market segments, market trends, and opportunities, and any further data you may need to thrive in the headache disorders industry. This headache disorders market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.